Cornstarch powder is widely used in medical gloves. Cornstarch particles, instead of talc, are very volatile and are able to adsorb high quantities of natural rubber latex (NRL) proteins including those that are responsible for hypersensitivity reactions to latex. 1 Cornstarch particles bearing NRL proteins are now considered as potent allergens as it can induce respiratory disorders like common aeroallergens, such as pollens or dust mites. A correlation between the increasing use of powdered gloves in workplaces and the prevalence of latex allergy has been demonstrated. 2 3 The use of powder-containing gloves in operating theatres induces contamination of the environment by cornstarch particles bearing NRL proteins. 4 Furthermore, Kujala and colleagues 5 have reported that airborne latex allergens correlate better with airborne glove powder than with the glove allergen content. The incidence of anaphylactic reactions during anaesthesia has been estimated to 1:13 000, and NRL was responsible in 16.6% of these cases. 6 Ruëff and colleagues 7 have reported a correlation between the occurrence of multiple surgical procedures and the increase in prevalence of sensitization to NRL in patients. Regarding these findings, patients need relevant protection during surgical procedures. In previous studies, we developed experimental models of NRL sensitization in guinea pigs either via peritoneal or respiratory route, using cornstarch as an allergen carrier. NRL-sensitized animals demonstrated airway hyper-responsiveness induced by NRL after specific bronchial challenge. In addition, the exposure either by peritoneal or respiratory routes to glove powder contaminated by NRL proteins, aggravated the respiratory disorders induced by NRL. 8 9 We reported recently a bacterial/viral filter used in anaesthesia (Pall TM BB25) that efficiently retained the NRL proteins. 10 In the present study, we tested the relevance of the Pall TM BB25 filter in prevention of NRL sensitization in guinea pigs. For this purpose the animals were placed in similar conditions of airway exposure as a patient connected to an artificial breathing system during surgical procedures. A BB25 filter was inserted at the top of the NRL-nebulizing system in order to retain NRL-contaminated cornstarch particles or NRL solubilized in saline solution. In addition, a model of sensitization to ovalbumin was also used for comparison to a well-known antigen.
Materials and methods

Animals
Male albino Dunkin-Hartley guinea pigs (weight: 300-350 g) were purchased from the Centre de Production Animale, Olivet, France. Animals were maintained on a standard diet in the animal facility of the UFR Biomédicale des Saints-Pères, Université Paris V, France. The animals were treated in accordance with the local Ethical Animal Care and Use Committee.
Antigen sources
All the NRL sources used in this study were the same as utilized previously. 8 9 The latex solution was prepared with a lyophilized non-ammoniated latex extract (C-serum) from a Hevea brasiliensis tree in Thailand. The lyophilized C-serum contained 57.2 mg latex antigenic proteins g À1 of lyophilizate determined with the Competitive Immunoassay for Antigenic Latex Proteins (CIALP), an ELISA method for the assessment of antigenic NRL proteins described elsewhere. 11 For the preparation of NRL in saline, C-serum was reconstituted in saline solution and diluted to 0.5 mg NRL antigenic proteins ml À1 . Latex-contaminated cornstarch (NRL-cornstarch) was collected in the slurry tank on the glove production line of a latex glove manufacturer in Thailand. Its antigenic NRL protein content was 0.85 mg g À1 of dry powder (CIALP). Virgin or non-contaminated cornstarch (Agenasorb 9020, Agrana Stärke GMBH, Wien, Austria) habitually used for powdering latex gloves that had never been in contact with NRL sources was utilized as a control for NRL-cornstarch.
Ovalbumin used for sensitization and challenge was a commercial reagent from Serlabo, France.
Sensitization protocol
The sensitization protocol was conducted exactly in the same manner as described previously. 9 Guinea pigs, separated in six groups (n=8-10 in each), were exposed to aerosolized NRL solubilized in saline or to NRL-cornstarch (10 mg of antigenic NRL proteins) once a day for 1 h for 2 weeks (2·5 days). The exposure was performed with or without a BB25 filter placed at the top side of the nebulizer. Control groups were exposed to saline alone or to non-contaminated cornstarch. All animals were challenged with NRL between days 31 and 33 of the sensitization protocol. Thirty minutes after bronchial challenge, the animals were bled and bronchoalveolar lavage (BAL) was performed. Two additional groups were exposed to 10 mg ovalbumin every day as described above with (ovalbumin+filter group, n=10) or without a BB25 filter (ovalbumin group, n=8) inserted in the aerosol system. The ovalbumin bronchial challenge and BAL were performed according to the NRL sensitization schedule described above.
Specific bronchial provocation
The degree of bronchoconstriction after NRL or ovalbumin challenge was evaluated by the Konzett and Rössler method, 12 modified as described previously. 8 Guinea pigs were anaesthetized with urethane intraperitoneally (1.5 g kg À1 ), the right carotid artery was catheterized and connected to an arterial pressure transducer (DPT 700-500, NARCO Biosystems, Houston, TX, USA). The animals were tracheotomized and connected to an artificial respiration pump (Braun, Melsungen, Germany) and a differential pressure transducer (PM5, Statham, LA, CA, USA). The ventilation parameters (volume and frequency) for each animal were calculated according to the table of Kleinman and Radford. 13 Anaesthetized animals were pre-treated with propranolol (2 mg kg À1 ) (Sigma, St Louis, MO, USA) at least 10 min before challenge to prevent possible bronchodilatation induced by catecholamines.
14 Challenge was then performed by instillation of 1 mg NRL or ovalbumin in 20 ml of saline solution directly into the lungs via the trachea. Pulmonary insufflation pressure variation and arterial pressure were recorded over 15 min with the differential pressure captor connected to a Physiograph E&M (NARCO Biosystems). The level of bronchoconstriction was determined after calculation of the area under the curve using the KaleidaGraph TM 3.09 software (Synergy Software, Reading, PA, USA).
Thromboxane B 2 determination in BAL fluid
Thirty minutes after NRL or ovalbumin challenge, BAL was performed as described below. Five millilitres of cold saline was instilled through the tracheal cannula then removed and re-injected five times with a 5 ml-syringe. The operation was repeated three times and the total volume of BAL fluid (BALF) was measured. BALF was centrifuged (15 min at 1000 g) and the supernatant stored at À20 C until assayed. Thromboxane (Tx) B 2 was determined in BALF with a commercial kit supplied by Cayman Chemical Company (TxB 2 EIA kit, Ann Arbor, MI, USA). The assay was performed according to the supplier's recommendations with a detection limit of 13 pg ml À1 .
Statistical analysis
Results were expressed as median (SEM) unless noticed otherwise. The Mann-Whitney U-test was used for comparisons between groups. A P<0.05 was considered as statistically significant.
Results
Sensitization with NRL
Following bronchial challenge guinea pigs exposed to NRL without a filter (i.e. NRL alone and NRL-cornstarch) demonstrated higher level of broncoconstriction compared with controls. Animals exposed in the presence of the BB25 filter exhibited an airway response similar to control (Fig. 1) . Calculation of the area under the curve showed a level of bronchoconstriction significantly higher for animals exposed to NRL without a filter compared with control (respectively, P<0.02 and P<0.001 for NRL and NRLcornstarch). Conversely, the level of bronchoconstriction in the groups exposed to NRL with the BB25 filter was not significantly different from control but significantly lower compared with those that have been treated without the filter (P<0.02) ( Table 1) . TxB 2 determination in BALF after bronchial challenge showed a significant increase of the production in the guinea pig lungs exposed to NRL (P<0.001) compared with control.
When the animals were exposed in the presence of the filter we observed a decrease in TxB 2 production compared with those exposed to NRL without a filter (P<0.04) ( Table 2) .
Sensitization with ovalbumin
Specific bronchial challenge performed after ovalbumin sensitization demonstrated an increase in bronchoconstriction compared with control group as shown by the area under the curve (P<0.001). Exposure in the presence of a filter resulted in a significant decrease in the pulmonary response (P<0.001 compared with ovalbumin), which was not different from control (Table 1 and Fig. 2 ).
TxB2 production in lungs also significantly increased after exposure to ovalbumin (P<0.001) compared with control. Exposure in the presence of the filter resulted in a significant decrease (P<0.04) compared with the ovalbumin group ( Table 2) .
Discussion
In a recent study we developed an animal model of NRL sensitization in guinea pigs exclusively conducted via the respiratory route 9 . The animals were exposed to aerosolized NRL solubilized in saline or to NRL-contaminated cornstarch glove powder. These animals demonstrated respiratory sensitivity as shown by a high level of bronchoconstriction induced after NRL challenge and an increase of the TxB 2 production in the lungs. This model confirms that the respiratory tract is a predominant route of sensitization to NRL proteins. The allergens carried by Preventing latex exposure during anaesthesia 1  3144  1768  855  926  1163  87  2791  1909  2  3170  1637  2185  1450  1248  506  6290  1339  3  2785  1347  260  1964  567  295  1425  863  4  2399  625  890  731  738  298  1078  824  5  2120  449  117  1574  1376  892  3731  1842  6  1183  1142  339  1551  974  69  2309  1443  7  1874  4571  536  1208  1259  146  2287  636  8  3764  823  13  1924  1211  431  2309  1963  9  1541  804  1568  711  181  1086  10  1442  1317  362   Median  2260  1245  670  1551  1163  297  2309 airborne glove cornstarch powder, contaminate the environment and can be inhaled. This explains why NRL-allergic health care workers (HCW) or patients can develop allergic reactions even though the use of gloves or other NRL-made devices is banned. We have also reported the role of cornstarch powder as an immunoadjuvant as airway responsiveness was increased in animals exposed to NRL-cornstarch compared with those treated with the same dose of NRL alone. The immunoadjuvant property of cornstarch in NRL-induced hypersensitivity was also demonstrated in a previous study in which guinea pigs were sensitized via the peritoneal route reproducing NRL sensitization of patients during surgical procedures. 8 The present study corroborates these findings as exposure to NRL in the presence of the BB25 filter significantly decreased bronchoconstriction and TxB 2 production in lungs after bronchial challenge. The inflammatory mediator TxA 2 and its more stable metabolite TxB 2 are not allergenspecific but they are known to be the most potent bronchoconstrictors in guinea pig airways. 15 Arakida and colleagues 16 also reported that TxA 2 was the mediator predominantly found in the lungs of passively sensitized guinea pigs exhibiting asthmatic reactions.
The capacity for retention of cornstarch and NRLcornstarch particles by the BB25 filter has already been tested. 10 In the present experiments, we confirmed in vivo that the BB25 filter is able to protect guinea pigs from NRL sensitization during exposure to airborne NRL-cornstarch particles or NRL solubilized proteins. Animals exposed to NRL with the BB25 filter exhibited airway responses similar to those of the controls. Exposure to the well-known antigen ovalbumin supported these findings. The high variability in pulmonary insufflation pressure observed may be the result of a variation of the dose of allergen effectively received. Guinea pigs were allowed to breathe spontaneously during the sensitization protocol, thus the dose of the NRL inhaled was not controlled. This variability was also observed in animals sensitized to ovalbumin.
NRL is known to be responsible for anaphylactic reactions in patients during surgical procedures in 16.6% of the cases. The severity of these reactions underlines that preanaesthetic detection of the triggering parameters is very important and the implementation of preventative measures is essential. Recent reports re-inforced the need to take measures to efficiently protect patients and/or HCW against NRL exposure.
17 18 The key elements are the establishment of an as close as possible latex-free environment and minimizing the exposure to latex either in primary or secondary prophylaxis. 19 20 For example, in a 5-yr prospective study on 100 children mostly with spina bifida, the anti-latex IgE was reduced in 64% of the patients by applying these procedures. 21 A notable efficiency in the HCW population was also observed. 22 23 As a result of the latex risk, NRL-made devices have been discarded from the operating theatre. However, in many hospitals, mechanical ventilation is still provided by older equipment with components containing NRL. The wear of such apparatus can lead to latex scatter within the piping, which can be inhaled by the patient. Nevertheless, the recommendations mentioned above are strengthened when a patient at risk is anaesthetized even when using a newer breathing system. Hence, some anaesthetists require that the viral and bacterial filter be inserted between the Ypiece and the patient to efficiently retain latex particles.
The BB25 filter has been developed for anaesthesia, it retains small airborne bacterial and viral contaminants with a retention efficiency of more than 99.999% (Brevundimonas diminuta, Bacteriophage MS2) and larger particles (Bacillus subtilis, Serratia marcescens) with a retention efficiency of more than 99.9999%. Its hydrophobic membrane prevents the passage of aqueous suspension of Mycobacterium bovis, Mycobacterium tuberculosis, HCV and HIV. The present study demonstrated that the use of this filter should contribute efficiently to the patient protection during surgery or any procedure necessitating mechanical ventilation. However, all other measures intended to avoid contact between the patient and NRL devices must be taken. Nakamura and colleagues 24 reported a high incidence of latex allergy in children requiring home mechanical ventilation.
Mitakakis and colleagues 25 have tested the efficiency of a particulate mask to protect HCW from airborne latex allergens. But to our knowledge, this is the first study of a device used to prevent latex-allergy reactions in patients.
